Literature DB >> 16186382

Interaction of glucokinase with the liver regulatory protein is conferred by leucine-asparagine motifs of the enzyme.

Simone Baltrusch1, Flavio Francini, Sigurd Lenzen, Markus Tiedge.   

Abstract

The glucokinase regulatory protein (GRP) plays a pivotal role in the regulation of metabolic flux in liver by the glucose-phosphorylating enzyme glucokinase. Random peptide phage display library screening for binding partners of GRP allowed the identification of an asparagine-leucine consensus motif. Asparagine-leucine motifs of glucokinase located in the hinge region, as well as in the large domain, were changed by site-directed mutagenesis. The L58R/N204Y and the L309R/N313Y glucokinase mutants showed a significantly reduced interaction with GRP. The L355R/N350Y mutant had a fivefold-higher binding affinity for GRP than wild-type glucokinase. Imaging of glucokinase and GRP fluorescence fusion proteins revealed that the L58R/N204Y glucokinase mutant lacked glucose-dependent translocation by GRP, whereas the L355R/N350Y glucokinase mutant was trapped in the nucleus due to high affinity for GRP. The results indicate that the L58/N204 motif in the hinge region confers binding to GRP, while the L355/N350 motif may modulate the binding affinity for GRP. This latter motif is part of the alpha10 helix of glucokinase and accessible to GRP in the free and complex conformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186382     DOI: 10.2337/diabetes.54.10.2829

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

1.  Mutational analysis of allosteric activation and inhibition of glucokinase.

Authors:  Bogumil Zelent; Stella Odili; Carol Buettger; Dorothy K Zelent; Pan Chen; Deborah Fenner; Joseph Bass; Charles Stanley; Monique Laberge; Jane M Vanderkooi; Ramakanth Sarabu; Joseph Grimsby; Franz M Matschinsky
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

Review 2.  A fresh view of glycolysis and glucokinase regulation: history and current status.

Authors:  Sigurd Lenzen
Journal:  J Biol Chem       Date:  2014-03-17       Impact factor: 5.157

3.  Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.

Authors:  C M García-Herrero; M Galán; O Vincent; B Flández; M Gargallo; E Delgado-Alvarez; E Blázquez; M A Navas
Journal:  Diabetologia       Date:  2006-12-21       Impact factor: 10.122

4.  Nitric Oxide Activates β-Cell Glucokinase by Promoting Formation of the "Glucose-Activated" State.

Authors:  Kendra M Seckinger; Vishnu P Rao; Nicole E Snell; Allison E Mancini; Michele L Markwardt; M A Rizzo
Journal:  Biochemistry       Date:  2018-08-10       Impact factor: 3.162

5.  Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent.

Authors:  Sara Langer; Martin T Kaminski; Sigurd Lenzen; Simone Baltrusch
Journal:  Mol Endocrinol       Date:  2010-08-11

Review 6.  Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.

Authors:  Anne Raimondo; Matthew G Rees; Anna L Gloyn
Journal:  Curr Opin Lipidol       Date:  2015-04       Impact factor: 4.776

7.  Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.

Authors:  Nicola L Beer; Martijn van de Bunt; Kevin Colclough; Christine Lukacs; Paul Arundel; Constance L Chik; Joseph Grimsby; Sian Ellard; Anna L Gloyn
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

8.  Monitoring of glucose-regulated single insulin secretory granule movement by selective photoactivation.

Authors:  S Baltrusch; S Lenzen
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

9.  Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner.

Authors:  Anke Hofmeister-Brix; Katrin Kollmann; Sara Langer; Julia Schultz; Sigurd Lenzen; Simone Baltrusch
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

10.  Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.

Authors:  M G Rees; S Wincovitch; J Schultz; R Waterstradt; N L Beer; S Baltrusch; F S Collins; A L Gloyn
Journal:  Diabetologia       Date:  2011-10-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.